Literature DB >> 1810024

Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis.

H Berner Berntzen1, G K Endresen, M K Fagerhol, J Spiechowicz, P Mowinckel.   

Abstract

Calprotectin (L1) is a major leukocyte protein which is released during activation or death of neutrophil granulocytes and monocytes. Previous studies have shown that L1 may be a useful marker of disease activity in patients with adult or juvenile rheumatoid arthritis (RA). In the present study, the plasma concentrations of L1 were analysed during shoulder-joint surgery in 16 patients with adult or juvenile RA. Decreased L1 concentrations were found 48 h postoperatively. Thereafter, the L1 concentrations were increased at 72 h, with a following decrease until day 14 postoperatively. In contrast, increased serum concentrations of both C-reactive protein (CRP) and orosomucoid (i.e. alpha 1-acid glycoprotein) were found at 48 h after surgery. Plasma samples obtained before and after surgery were analysed by gel filtration. Approximately 3/4 of the plasma L1 was found in fractions corresponding to the native molecule, while the rest was detected in higher molecular mass fractions. The distribution of L1 antigen in low and high molecular mass regions did not differ between the pre- and postoperative plasma samples. The L1 protein consists of light and heavy chains. Increased serum levels of the cystic fibrosis antigen, which is identical to L1 light chain, have been described in patients with cystic fibrosis. The existence of circulating free L1 chains was presently investigated in plasma obtained before and after surgery. After gel filtration of plasma samples, no free L1 chains were detected by use of enzyme immunoassay and dot blot.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810024     DOI: 10.3109/00365519109104575

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?

Authors:  M K Fagerhol
Journal:  Clin Mol Pathol       Date:  1996-04

Review 2.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

3.  Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein).

Authors:  C F Naess-Andresen; B Egelandsdal; M K Fagerhol
Journal:  Clin Mol Pathol       Date:  1995-10

4.  Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs.

Authors:  Ingrid Hang; Romy M Heilmann; Niels Grützner; Jan S Suchodolski; Jörg M Steiner; Faik Atroshi; Satu Sankari; Anu Kettunen; Willem M de Vos; Jürgen Zentek; Thomas Spillmann
Journal:  BMC Vet Res       Date:  2013-10-09       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.